Molecular therapeutics of pancreatic ductal adenocarcinoma:targeted pathways and the role of cancer stem cells
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in humans due to late detection and highly metastatic characteristics. PDAC cells vary in their tumorigenic capabilities with the presence of a subset of PDAC cells known as pancreatic cancer stem cells (CSCs), which are more...
Автори: | Stoica, A, Chang, C-H, Pauklin, S |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Cell Press
2020
|
Схожі ресурси
Схожі ресурси
-
Mechanisms of cancer cell death: Therapeutic implications for pancreatic ductal adenocarcinoma
за авторством: Pook, H, та інші
Опубліковано: (2021) -
In-silico identification of therapeutic targets in pancreatic ductal adenocarcinoma using WGCNA and Trader
за авторством: Parvin Yavari, та інші
Опубліковано: (2024-10-01) -
TRP Channels Interactome in Pancreatic Ductal Adenocarcinoma: A Potential Therapeutic Target
за авторством: Ahmad Taha Khalaf, та інші
Опубліковано: (2023-03-01) -
Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
за авторством: Gitika Thakur, та інші
Опубліковано: (2021-02-01) -
Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
за авторством: Jinlu Liu, та інші
Опубліковано: (2023-10-01)